表紙:シングルセルシーケンシングの世界市場 - 分析と予測:2018-2029年
市場調査レポート
商品コード
929404

シングルセルシーケンシングの世界市場 - 分析と予測:2018-2029年

Global Single Cell Sequencing Market: Focus on Products, Applications, Technologies, End Users, Country Data (17 Countries), and Competitive Landscape - Analysis and Forecast, 2018-2029

出版日: | 発行: BIS Research Inc. | ページ情報: 英文 189 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=114.87円
シングルセルシーケンシングの世界市場 - 分析と予測:2018-2029年
出版日: 2020年02月17日
発行: BIS Research Inc.
ページ情報: 英文 189 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のシングルセルシーケンシング市場規模は、2019年から2029年の予測期間中、15.24%のCAGRで大幅に成長すると予測されています。同市場規模は、2018年に12億3,400万米ドルの収益を生成しました。世界のシングルセルシーケンシング市場の成長は主に、試行錯誤的医療への依存を減らすことによる非侵襲的治療への注目の高まり、シングルセルゲノミクスによる遺伝子発現レベルおよびタンパク質発現レベルの分析の同時進行、新しいシーケンシング技術の登場、および細胞分離技術の進歩などに起因しています、しかし、医療費償還と規制政策の不確実性、高額な資本の要件、バイオインフォマティクスソリューションが利用できないこと、および高額な標的治療薬と遺伝子シーケンシング手順などが、同市場の成長を抑制する課題となっています。

当レポートでは、世界のシングルセルシーケンシング市場について取り上げ、市場ダイナミクス、競合環境、各セグメント・地域別の市場、競合状況、および主要企業などについて詳細に分析しています。

エグゼクティブサマリー

第1章 調査範囲

第2章 調査手法

第3章 市場力学

  • 事業の成長要因
    • 非侵襲的な診断の必要性
    • シングルセルシーケンシング技術の進歩
    • 個別化医療の採用の増加
  • 事業課題
    • 計算分析のためのツールの欠如
    • 高い資本要件
    • インフラストラクチャー・専門知識の欠如
  • 法的要件と規制
  • 市場機会マップ(市場-アプリケーション-製品)
    • 新興市場への拡大
    • 新しい調査アプリケーションへの拡大
    • 製品ポートフォリオの拡大

第4章 世界のシングルセルシーケンシング市場

  • 単一細胞分離
    • 蛍光活性化セルソーティング(FACS)
    • レーザーキャプチャマイクロダイセクション(LCM)
    • マイクロフルイディクス
    • デジタル誘電泳動ソーティング(DEPArray)
    • その他の技術
  • 単一細胞増幅
    • 複数変位増幅(MDA)
    • マルチプルアニーリングとループベースの増幅(MALBAC)
    • ポリメラーゼ連鎖反応(ddPCRおよびDOP-PCR)
    • トランスポゾン挿入による線形増幅(LIANTI)
    • その他の技術
  • シングルセルシーケンシング
    • シングルセルトランスクリプトームシーケンス(Sc-RNAシーケンス)
    • シングルセル全ゲノムシーケンス(WGS)
    • シングルセルゲノムとトランスクリプトームの並列シーケンス
    • シングルセルHi-Cシーケンス
    • scRRBS
    • シングルセル全ゲノムバイサルファイトシーケンス(WGBS)
  • 関連技術の進歩

第5章 世界のシングルセルシーケンシング市場:製品別

  • 装置
    • 次世代シーケンシングシステム
    • ポリメラーゼ連鎖反応
    • マイクロアレイシステム
    • フローサイトメーター
    • その他
  • 消耗品
    • アッセイキット
    • ビーズ
    • マイクロプレート
    • その他の消耗品

第6章 世界のシングルセルシーケンシング市場:アプリケーション別

  • 腫瘍学
  • 免疫学
  • 神経学
  • 微生物学
  • 出産前診断(NIPT)
  • その他

第7章 世界のシングルセルシーケンシング市場:エンドユーザー別

  • シングルセルシーケンスのエンドユーザータイプ
    • 調査および研究所
    • バイオ医薬品およびバイオテクノロジー企業
    • その他(病院、診療所、診断検査室)
  • シングルセルシーケンスのエンドユーザーの嗜好

第8章 世界のシングルセルシーケンス市場: 競合情勢

  • 主要企業の成長率と市場シェア
  • 事業戦略
  • 企業の発展

第9章 世界のシングルセルシーケンシング市場:地域別

  • 概要
  • 北米
  • 欧州
  • アジア太平洋地域
  • ラテンアメリカ
  • その他

第10章 企業プロファイル

  • 10x Genomics Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • BGI Genomics Co. Ltd.
  • Celsee Inc.
  • Fluidigm Corporation
  • Fluxion Biosciences
  • Illumina, Inc.
  • Mission Bio
  • NanoString Technologies, Inc.
  • PerkinElmer, Inc.
  • QIAGEN N.V.
  • タカラバイオ
  • Thermo Fisher Scientific Inc.
図表

List of Tables

  • Table 1: Impact Analysis
  • Table 2: Impact Analysis: Market Restraints
  • Table 3.1: Regulatory Bodies and Consortiums of Single Cell Sequencing Market
  • Table 3.2: Classification of Directive Groups IVDs
  • Table 4.1: Products for Fluorescence-Activated Cell Sorting
  • Table 4.2: Multiple Annealing and Looping-Based Amplification-Based Products for Single Cell Analysis
  • Table 4.3: PCR-Based Products for Single Cell Isolation
  • Table 4.4: Products Offered for Single Cell Transcriptome Sequencing
  • Table 4.5: Products Offered for Single Cell Whole Genome Sequencing
  • Table 8.1: Single Cell Sequencing Research Funding

List of Figures

  • Figure 1: Market Dynamics of Global Single Cell Sequencing Market
  • Figure 2: Drivers of Next-Generation Sequencing Market
  • Figure 3: Restraints of Next-Generation Sequencing Market
  • Figure 4: Global Single Cell Sequencing Market Snapshot
  • Figure 5: Dominating Segments of the Global Single Cell Sequencing, 2018 and 2029
  • Figure 6: Global Single Cell Sequencing Market Share (by Product), 2018-2029
  • Figure 7: Global Single Cell Sequencing Market Share (by Workflow), 2018-2029
  • Figure 8: Global Single Cell Sequencing Market Share (by End User), 2018-2029
  • Figure 9: Global Single Cell Sequencing Market Share (by Application), 2018-2029
  • Figure 1.1: Global Single Cell Sequencing Market Segmentation
  • Figure 2.1: Global Single Cell Sequencing Market Research Methodology
  • Figure 2.2: Bottom-Up Approach (Segment-Wise Analysis)
  • Figure 2.3: Top-Down Approach (Segment-Wise Analysis)
  • Figure 4.1: Single Cell Isolation Methods
  • Figure 4.2: Global Single Cell Isolation Market, 2018-2029
  • Figure 4.3: Global Single Cell Fluorescence-Activated Cell Sorting Market, 2018-2029
  • Figure 4.4: Global Single Cell Laser Capture Microdissection Market, 2018-2029
  • Figure 4.5: Global Single Cell Microfluidics Market, 2018-2029
  • Figure 4.6: Global Single Cell DEPArray Market, 2018-2029
  • Figure 4.7: Global Single Cell Other Single Cell Isolation Technologies Market, 2018-2029
  • Figure 4.8: Global Single Cell Sequencing Amplification Market, 2018-2029
  • Figure 4.9: Global Single Cell Sequencing Multiple Displacement Amplification Market, 2018-2029
  • Figure 4.10: Global Single Cell Micro-Capillary Array Emulsion Multiple Displacement Amplification Market, 2018-2029
  • Figure 4.11: Global Single Droplet Multiple Displacement Amplification Market, 2018-2029
  • Figure 4.12: Global Compartmented Droplet Multiple Displacement Amplification Market, 2018-2029
  • Figure 4.13: Global Single Cell MALBAC Market, 2018-2029
  • Figure 4.14: Global Single Cell Polymerase Chain Reaction (ddPCR and DOP-PCR) Market, 2018-2029
  • Figure 4.15: Global Single LIANTI Market, 2018-2029
  • Figure 4.16: Global Single Cell Other Amplification Technologies Market, 2018-2029
  • Figure 4.17: Global Single Cell Sequencing Market, 2018-2029
  • Figure 4.18: Global Single Cell Transcriptome Sequencing Market, 2018-2029
  • Figure 4.19: Global Single Cell Whole Genome Sequencing (WGS) Market, 2018-2029
  • Figure 4.20: Global Single Cell Genome and Transcriptome Parallel Sequencing Market, 2018-2029
  • Figure 4.21: Global Single Cell Hi-C Sequencing Market, 2018-2029
  • Figure 4.22: Global Single Cell Reduced Representation Bisulfide Sequencing Market, 2018-2029
  • Figure 4.23: Global Single Cell Whole Genome Bisulfite Sequencing Market, 2018-2029
  • Figure 4.24: Three Major Technological Developments in Single Cell Sequencing
  • Figure 4.25: Traditional and Modern Approaches for Single Cell Isolation
  • Figure 5.1: Global Single Cell Sequencing (by Product Type), 2018 and 2029
  • Figure 5.2: Global Single Cell Sequencing Instruments Market, 2018-2029
  • Figure 5.3: Global Single Cell Sequencing NGS System Market, 2018-2029
  • Figure 5.4: Global Single Cell Sequencing PCR Market, 2018-2029
  • Figure 5.5: Global Single Cell Sequencing Microarray Systems Market, 2018-2029
  • Figure 5.6: Global Single Cell Sequencing Flow Cytometer Market, 2018-2029
  • Figure 5.7: Global Single Cell Sequencing Other Instruments Market, 2018-2029
  • Figure 5.8: Global Single Cell Sequencing Consumables Market, 2018-2029
  • Figure 5.9: Global Single Cell Sequencing Assay Kits Market, 2018-2029
  • Figure 5.10: Global Single Cell Sequencing Beads Market, 2018-2029
  • Figure 5.11: Global Single Cell Sequencing Microplates Market, 2018-2029
  • Figure 5.12: Global Single Cell Sequencing Other Consumables Market, 2018-2029
  • Figure 6.1: Global Single Cell Sequencing Market for Oncology (2018-2029)
  • Figure 6.2: Global Single Cell Sequencing Market for Immunology (2018-2029)
  • Figure 6.3: Global Single Cell Sequencing Market for Neurology (2018-2029)
  • Figure 6.4: Global Single Cell Sequencing Market for Microbiology (2018-2029)
  • Figure 6.5: Global Single Cell Sequencing Pre-Natal Market (2018-2029)
  • Figure 6.6: Global Single Cell Sequencing Other Application Market (2018-2029)
  • Figure 7.1: Global Single Cell Sequencing Market (Research and Academia), 2018-2029
  • Figure 7.2: Global Single Cell Sequencing Market, (Biopharmaceutical and Biotech Companies), 2018-2029
  • Figure 7.3: Global Single Cell Sequencing Market (Others), 2018-2029
  • Figure 7.4: End User Preference of Instruments (by Major Brand) (N=35)
  • Figure 7.5: End User Satisfaction Level of Instruments (by Brand) (N=35) (1 being lowest and 5 being the highest)
  • Figure 7.6: Customer Preference for Cell Types Used in Single Cell Sequencing (N=35)
  • Figure 7.7: End User Preferred Technology for Single Cell Isolation (N=35)
  • Figure 7.8: End User Perception on Challenges in Single Cell Sequencing (N=35) (where 1= not limiting and 5= extremely limiting)
  • Figure 8.1: Growth Rate and Market Share Matrix for Global SCS Market, 2018
  • Figure 8.2: Market Shares of Key Players in Global Single Cell Sequencing Market, 2018
  • Figure 8.3: Product Launches Share (by Companies), January 2016-April 2019
  • Figure 8.4: Synergistic Activities Share (by Companies), January 2016 - April 2019
  • Figure 8.5: Number of Acquisitions (by Company), January 2016-April 2019
  • Figure 9.1: Global Single Cell Sequencing Market (by Region), 2018 and 2029
  • Figure 9.2: Global Single Cell Sequencing Market (by Region), 2018-2029
  • Figure 9.3: Global Single Cell Sequencing Market Share (by Region), 2018
  • Figure 9.4: Global Single cell Sequencing Market Share (by Region), 2029
  • Figure 9.5: North America Global Single Cell Sequencing Market, 2018-2029
  • Figure 9.6: North America: Market Dynamics
  • Figure 9.7: North America Single Cell Sequencing Market (by Country), 2018-2029
  • Figure 9.8: U.S. Single Cell Sequencing Market, 2018-2029
  • Figure 9.9: Canada Single Cell Sequencing Market, 2018-2029
  • Figure 9.10: Europe Single Cell Sequencing Market, 2018-2029
  • Figure 9.11: Europe: Market Dynamics
  • Figure 9.12: Europe Global Single Cell Sequencing Market (by Country), 2018-2029
  • Figure 9.13: Germany Single Cell Sequencing Market, 2018-2029
  • Figure 9.14: France Single Cell Sequencing Market, 2018-2029
  • Figure 9.15: U.K. Single Cell Sequencing Market, 2018-2029
  • Figure 9.16: Italy Single Cell Sequencing Market, 2018-2029
  • Figure 9 17: Spain Single Cell Sequencing Market, 2018-2029
  • Figure 9.18: Rest-of-Europe Single Cell Sequencing Market, 2018-2029
  • Figure 9.19: Asia-Pacific Single Cell Sequencing Market, 2018-2029
  • Figure 9.20: APAC: Market Dynamics
  • Figure 9.21: APAC Single Cell Sequencing Market (by Country), 2018-2029
  • Figure 9.22: China Single Cell Sequencing Market, 2018-2029
  • Figure 9.23: Japan Single Cell Sequencing Market, 2018-2029
  • Figure 9.24: Australia Single Cell Sequencing Market, 2018-2029
  • Figure 9.25: India Single Cell Sequencing Market, 2018-2029
  • Figure 9.26: South Korea Single Cell Sequencing Market, 2018-2029
  • Figure 9.27: Singapore Single Cell Sequencing Market, 2018-2029
  • Figure 9.28: RoAPAC Single Cell Sequencing Market, 2018-2029
  • Figure 9.29: Latin America Single Cell Sequencing Market, 2018-2029
  • Figure 9.30: Latin America: Market Dynamics
  • Figure 9.31: Latin America Single Cell Sequencing Market (by Country), 2018-2029
  • Figure 9.32: Brazil Single Cell Sequencing Market, 2018-2029
  • Figure 9.33: Mexico Single Cell Sequencing Market, 2018-2029
  • Figure 9.34: Rest-of-Latin America Single Cell Sequencing Market, 2018-2029
  • Figure 9.35: RoW Single Cell Sequencing Market, 2018-2029
  • Figure 10.1: 10x Genomics Inc.: SWOT Analysis
  • Figure 10.2: Becton, Dickinson and Company: Overall Financials, 2016-2018
  • Figure 10.3: Becton, Dickinson and Company: Revenue (by Business Segment), 2015-2018
  • Figure 10.4: Becton, Dickinson and Company: Revenue (by Region), 2015-2018
  • Figure 10.5: Becton, Dickinson and Company: R&D Expenditure, 2016-2018
  • Figure 10.6: Becton, Dickinson and Company: SWOT Analysis
  • Figure 10.7: Bio-Rad Laboratories, Inc.: Overall Financials, (2016-2018)
  • Figure 10.8: Bio-Rad Laboratories, Inc.: Revenue (by Business Segment), 2016-2018
  • Figure 10.9: Bio-Rad Laboratories, Inc.: Revenue (by Region), 2016-2018
  • Figure 10.10: Bio-Rad Laboratories, Inc., R&D Expenditure, 2016-2018
  • Figure 10.11: Bio-Rad Laboratories, Inc.: SWOT Analysis
  • Figure 10.12: BGI: SWOT Analysis
  • Figure 10.13: Celsee Inc.: SWOT Analysis
  • Figure 10.14: Fluidigm Corporation: Overall Financials, 2016-2018
  • Figure 10.15: Fluidigm Corporation: Revenue (by Business Segment), 2016-2018
  • Figure 10.16: Fluidigm Corporation: Revenue (by Region), 2016-2018
  • Figure 10.17: Fluidigm Corporation: R&D Expenditure, 2016-2018
  • Figure 10.18: Fluidigm Corporation: SWOT Analysis
  • Figure 10.19: Fluxion Biosciences: SWOT Analysis
  • Figure 10.20: Illumina Inc.: Overall Financials, (2016-2018)
  • Figure 10.21: Illumina, Inc.: Revenue (by Business Segment), 2016-2018
  • Figure 10.22: Illumina, Inc.: Revenue (by Region), 2016-2018
  • Figure 10.23: Illumina, Inc., R&D Expenditure, 2016-2018
  • Figure 10.24: Illumina, Inc. SWOT Analysis
  • Figure 10.25: Mission Bio: SWOT Analysis
  • Figure 10.26: NanoString Technologies, Inc.: Overall Financials, (2016-2018)
  • Figure 10.27: NanoString Technologies, Inc.: Revenue (by Business Segment), 2016-2018
  • Figure 10.28: NanoString Technologies, Inc.: Revenue (by Region), 2016-2018
  • Figure 10.29: NanoString Technologies, Inc.: R&D Expenditure, 2016-2018
  • Figure 10.30: NanoString Technologies, Inc.: R&D Expenditure (by Functional Area), 2016-2018
  • Figure 10.31: NanoString Technologies: SWOT Analysis
  • Figure 10.32: Perkin Elmer, Inc.: Overall Financials, (2016-2018)
  • Figure 10.33: Perkin Elmer, Inc.: Revenue (by Business Segment), 2016-2018
  • Figure 10.34: Perkin Elmer, Inc.: Revenue (by Region), 2016-2018
  • Figure 10.35: PerkinElmer, Inc., Inc.: R&D Expenditure, 2016-2018
  • Figure 10.36: PerkinElmer, Inc.: SWOT Analysis
  • Figure 10.37: QIAGEN N.V..: Overall Financials, (2015-2017)
  • Figure 10.38: QIAGEN N.V.: Revenue (by Business Segment), 2015-2017
  • Figure 10.39: QIAGEN N.V.: Revenue (by Region), 2015-2017
  • Figure 10.40: QIAGEN N.V.: R&D Expenditure, 2015-2017
  • Figure 10.41: QIAGEN N.V.: SWOT Analysis
  • Figure 10.42: Takara Bio Inc.: Overall Financials, (2016-2018)
  • Figure 10.43: Takara Bio, Inc.: Revenue (by Business Segment), 2016-2018
  • Figure 10.44: Takara Bio, Inc.: Revenue (by Region), 2017
  • Figure 10.45: Takara Bio, Inc., R&D Expenditure, 2015-2017
  • Figure 10.46: Takara Bio Inc.: SWOT Analysis
  • Figure 10.47: Thermo Fisher Scientific Inc.: Product Portfolio
  • Figure 10.48: Thermo Fisher Scientific Inc.: Overall Financials, 2016-2018
  • Figure 10.49: Thermo Fisher Scientific Inc.: Revenue (by Segment), 2016-2018
  • Figure 10.50: Thermo Fisher Scientific Inc.: Revenue (by Region), 2016-2018
  • Figure 10.51: Thermo Fisher Scientific Inc.: R&D Expenditure, 2016-2018
  • Figure 10.52: Thermo Fisher Scientific Inc.: SWOT Analysis
目次
Product Code: BH169A

Global Single Cell Sequencing Market to Grow at a CAGR of 15.24% from 2019-2029

Key Questions Answered in this Report:

  • What are the major market drivers, challenges, and opportunities in the global single cell sequencing market?
  • What are the underlying structures resulting in the emerging trends within the global single cell sequencing market?
  • How is each segment of the global single cell sequencing market expected to grow during the forecast period and what is the estimated revenue to be generated by each of the segments by the end of 2029?
  • What is the expected compound growth rate to be witnessed by the leading players in the market during the forecast period 2019-2029?
  • What are the key applications in the global single cell sequencing market? What are the major segments of these applications?
  • Who are the key manufacturers the global single cell sequencing market, and what are their contributions?

Global Single Cell Sequencing Market Forecast

The single cell sequencing industry analysis by BIS Research projects the market to grow at a significant CAGR of 15.24% during the forecast period, 2019-2029. The single cell sequencing market generated $1,234.0 million revenue in 2018, in terms of value. The global single cell sequencing market growth has been primarily attributed to the major drivers in this market such as increasing focus on non-invasive therapy by decreasing dependence on trial and error medicine, analysis of gene expression level and protein expression level simultaneously through single cell genomics, emergence of new sequencing techniques, and advancements in cell isolation techniques. However, there are significant challenges which are restraining the market growth. These challenges include the uncertain reimbursement and regulatory policies, high capital requirement, unavailability of bioinformatics solutions, and high cost of targeted therapeutic drugs and gene sequencing procedures.

Expert Quote

"Research programs such as Single Cell Analysis Project and Human Cell Atlas have been initiated to enhance this technology, consequentially increasing the awareness and adoption among patients and healthcare providers."

Scope of the Market Intelligence on the Single Cell Sequencing Market

The single cell sequencing research provides a holistic view of the market in terms of various factors influencing it, including regulatory reforms, and technological advancements.

The scope of this report is centered upon conducting a detailed study of the products and manufacturers allied with the market. In addition, the study also includes exhaustive information on the unmet needs, perception on the new products, competitive landscape, market share of leading manufacturers, growth potential of each underlying sub-segment, and company, as well as other vital information with respect to global single cell sequencing market.

Market Segmentation

  • The global single cell sequencing market segmentation (on the basis of product) is segmented into instrument and consumables.
  • The global single cell sequencing market segmentation (on the basis of workflow) is segmented into ingle cell isolation, single cell preparation, and single cell analysis.
  • The global single cell sequencing market segmentation (on the basis of end user) is segmented into academic & research laboratories, biotechnology & biopharmaceutical companies, and others end user segment.
  • The global single cell sequencing market segmentation (on the basis of application) is segmented into oncology, immunology, neurology, prenatal diagnosis (NIPT), microbiology, and others.
  • The global single cell sequencing market segmentation (on the basis of region) is segmented into North America, Europe, Asia-Pacific, Latin America, and Rest-of-the-World.

Key Companies in the Single Cell Sequencing Market

The key manufacturers who have been contributing significantly to the global single cell sequencing market include 10x Genomics, Inc., 1CellBio, MissionBio, NanoString Technologies, Inc., Fluidigm Corporation, Fluxion Biosciences, Bio-Rad Laboratories, Inc., Becton, Dickinson and Company, Celsee, Inc., BGI Genomics Co. Ltd. GE LifeSciences, Illumina, Inc., Takara Bio, Inc., Perkin Elmer, and Inc. QIAGEN N.V., among others.

Table of Contents

Executive Summary

1 Research Scope

  • 1.1 Product Definition
  • 1.2 Scope of the Study
  • 1.3 Key Questions Answered in the Report

2 Research Methodology

  • 2.1 Data Sources
    • 2.1.1 Primary Data Sources
    • 2.1.2 Secondary Data Sources
  • 2.2 Market Estimation Model
    • 2.2.1 Factors Considered for Data Prediction and Modeling
    • 2.2.2 Assumptions and Limitations

3 Market Dynamics

  • 3.1 Business Drivers
    • 3.1.1 Need for Non-Invasive Diagnosis
    • 3.1.2 Advancements in Single Cell Sequencing Techniques
    • 3.1.3 Increase in Adoption of Personalized Medicine
  • 3.2 Business Challenges
    • 3.2.1 Lack of Tools for Computational Analysis
    • 3.2.2 High Capital Requirement
    • 3.2.3 Lack of Infrastructure and Expertise
  • 3.3 Legal Requirements and Regulations
    • 3.3.1 Legal Requirements and Framework in the U.S.
    • 3.3.2 Legal Requirements and Regulations in Europe
    • 3.3.3 Legal Requirements and Framework in Asia-Pacific
      • 3.3.3.1 China
      • 3.3.3.2 Japan
  • 3.4 Opportunity MAP (Markets - Applications - Products)
    • 3.4.1 Expansion into Emerging Markets
    • 3.4.2 Expansion into New Research Application
    • 3.4.3 Expansion of the Product Portfolio

4 Global Single Cell Sequencing Market (by Workflow), 2018-2029

  • 4.1 Single Cell Isolation
    • 4.1.1 Fluorescence-Activated Cell Sorting (FACS)
    • 4.1.2 Laser Capture Microdissection (LCM)
    • 4.1.3 Microfluidics
    • 4.1.4 Digital Dielectrophoretic Sorting (DEPArray)
    • 4.1.5 Other Technologies
  • 4.2 Single Cell Amplification
    • 4.2.1 Multiple Displacement Amplification (MDA)
      • 4.2.1.1 Micro-Capillary Array Emulsion Multiple Displacement Amplification (MiCA-eMDA)
      • 4.2.1.2 Single Droplet Multiple Displacement Amplification (sd-MDA)
      • 4.2.1.3 Compartmented Droplet Multiple Displacement Amplification (Cd-MDA)
    • 4.2.2 Multiple Annealing and Looping-Bases Amplification (MALBAC)
    • 4.2.3 Polymerase Chain Reaction (ddPCR and DOP-PCR)
    • 4.2.4 Linear Amplification via Transposon Insertion (LIANTI)
    • 4.2.5 Other Technologies
  • 4.3 Single Cell Sequencing
    • 4.3.1 Single Cell Transcriptome Sequencing (Sc-RNA Sequencing)
    • 4.3.2 Single Cell Whole Genome Sequencing (WGS)
    • 4.3.3 Single Cell Genome and Transcriptome Parallel Sequencing
    • 4.3.4 Single Cell Hi-C Sequencing
    • 4.3.5 Single Cell Reduced Representation Bisulfite Sequencing (scRRBS)
    • 4.3.6 Single Cell Whole-Genome Bisulfite Sequencing (WGBS)
  • 4.4 Affiliated Technological Advancements
    • 4.4.1 Advancements in Imaging Techniques for Single Cell Sequencing
    • 4.4.2 Advancements in Single Cell Collection and Analysis System

5 Global Single Cell Sequencing Market, by Product, 2018-2029 ($Million)

  • 5.1 Instruments
    • 5.1.1 Next-Generation Sequencing Systems
    • 5.1.2 Polymerase Chain Reaction
    • 5.1.3 Microarray Systems
    • 5.1.4 Flow Cytometer
    • 5.1.5 Others
  • 5.2 Consumables
    • 5.2.1 Assay Kits
    • 5.2.2 Beads
    • 5.2.3 Microplates
    • 5.2.4 Other Consumables

6 Global Single Cell Sequencing Market (by Application), $Million, 2018-2029

  • 6.1 Oncology
  • 6.2 Immunology
  • 6.3 Neurology
  • 6.4 Microbiology
  • 6.5 Pre-Natal Diagnosis (NIPT)
  • 6.6 Others

7 Global Single Cell Sequencing Market (by End User), $Million, 2018-2029

  • 7.1 Single Cell Sequencing End User Types
    • 7.1.1 Research and Academic Laboratories
    • 7.1.2 Biopharmaceutical and Biotech Companies
    • 7.1.3 Others (Hospitals, Clinics, and Diagnostic Labs)
  • 7.2 Single Cell Sequencing End User Preferences
    • 7.2.1 End User Preference and Satisfaction Level of Different Instruments (by Brand)
    • 7.2.2 End User Preference for Cell Types Used in Single Cell Sequencing
    • 7.2.3 End User Preferred Technology for Single Cell Isolation
    • 7.2.4 End User Perception for Challenges in Single Cell Sequencing

8 Global Single Cell Sequencing Market: Competitive Landscape

  • 8.1 Growth Rates and Market Shares of Key Players
  • 8.2 Business Strategies
    • 8.2.1 Product Launches
    • 8.2.2 Expanding Presence through Partnerships, Joint Ventures, and Collaborations
  • 8.3 Corporate Developments
    • 8.3.1 Mergers and Acquisitions
    • 8.3.2 Funding

9 Global Single Cell Sequencing Market, by Region, 2018-2029 ($Million)

  • 9.1 Overview
  • 9.2 North America
    • 9.2.1 U.S.
    • 9.2.2 Canada
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 France
    • 9.3.3 U.K.
    • 9.3.4 Italy
    • 9.3.5 Spain
    • 9.3.6 Rest-of-Europe
  • 9.4 Asia-Pacific
    • 9.4.1 China
    • 9.4.2 Japan
    • 9.4.3 Australia
    • 9.4.4 India
    • 9.4.5 South Korea
    • 9.4.6 Singapore
    • 9.4.7 Rest-of-APAC
  • 9.5 Latin America
    • 9.5.1 Brazil
    • 9.5.2 Mexico
    • 9.5.3 Rest-of-Latin America
  • 9.6 Rest-of-the-World

10 Company Profiles

  • 10.1 10x Genomics Inc.
    • 10.1.1 Company Overview
    • 10.1.2 Role of 10x Genomics Inc. in the Global Single Cell Sequencing Market
    • 10.1.3 SWOT Analysis
  • 10.2 Becton, Dickinson and Company
    • 10.2.1 Company Overview
    • 10.2.2 Role of Becton, Dickinson and Company in the Global Single Cell Sequencing Market
    • 10.2.3 Key Insights About Financial Health of the Company
    • 10.2.4 SWOT Analysis
  • 10.3 Bio-Rad Laboratories, Inc.
    • 10.3.1 Company Overview
    • 10.3.2 Role of Bio-Rad Laboratories, Inc. in the Global Single Cell Sequencing Market
    • 10.3.3 Key Insights About Financial Health of the Company
    • 10.3.4 SWOT Analysis
  • 10.4 BGI Genomics Co. Ltd.
    • 10.4.1 Company Overview
    • 10.4.2 Role of BGI in the Single-Cell Sequencing Market
    • 10.4.3 SWOT Analysis
  • 10.5 Celsee Inc.
    • 10.5.1 Company Overview
    • 10.5.2 Role of Celsee Inc. in the Global Single Cell Sequencing Market
    • 10.5.3 SWOT Analysis
  • 10.6 Fluidigm Corporation
    • 10.6.1 Company Overview
    • 10.6.2 Role of Fluidigm Corporation in the Global Single Cell Sequencing Market
    • 10.6.3 Key Insights About Financial Health of the Company
    • 10.6.4 SWOT ANALYSIS
  • 10.7 Fluxion Biosciences
    • 10.7.1 Company Overview
    • 10.7.2 Role of Fluxion Biosciences in the Global Single Cell Sequencing Market
    • 10.7.3 SWOT Analysis
  • 10.8 Illumina, Inc.
    • 10.8.1 Company Overview
    • 10.8.2 Role Illumina, Inc. in the Global Single Cell Sequencing Market
    • 10.8.3 Key Insights About Financial Health of the Company
    • 10.8.4 SWOT Analysis
  • 10.9 Mission Bio
    • 10.9.1 Company Overview
    • 10.9.2 Role of Mission Bio in the Single Cell Sequencing Market
    • 10.9.3 SWOT Analysis
  • 10.10 NanoString Technologies, Inc.
    • 10.10.1 Company Overview
    • 10.10.2 Role of NanoString Technologies, Inc. in the Global Single Cell Sequencing Market
    • 10.10.3 Key Insights About Financial Health of the Company
    • 10.10.4 SWOT Analysis
  • 10.11 PerkinElmer, Inc.
    • 10.11.1 Company Overview
    • 10.11.2 Role of PerkinElmer, Inc. in the Global Single Cell Sequencing Market
    • 10.11.3 Key Insights About Financial Health of the Company
    • 10.11.4 SWOT Analysis
  • 10.12 QIAGEN N.V.
    • 10.12.1 Company Overview
    • 10.12.2 Role of QIAGEN N.V. in the Global Single Cell Sequencing Market
    • 10.12.3 Key Insights About Financial Health of the Company
    • 10.12.4 SWOT Analysis
  • 10.13 Takara Bio, Inc.
    • 10.13.1 Company Overview
    • 10.13.2 Role of Takara Bio, Inc. in the Global Single Cell Sequencing Market
    • 10.13.3 Key Insights About Financial Health of the Company
    • 10.13.4 SWOT Analysis
  • 10.14 Thermo Fisher Scientific Inc.
    • 10.14.1 Company Overview
    • 10.14.2 Role of Thermo Fisher Scientific Inc. in the Global Single Cell Sequencing Market
    • 10.14.3 Financials
    • 10.14.4 Key Insights About Financial Health of the Company
    • 10.14.5 SWOT Analysis